What is Veeva Systems history?
Veeva Systems began in 2007 in Pleasanton, California, when Peter Gassner built cloud software for life sciences. It focused on sales and compliance tools for drug makers, where trust and audit rules matter. That niche became its edge.
From a narrow start, Veeva Systems grew into a public leader in regulated software. Its story is tied to specialization, high switching costs, and steady execution. See Veeva Systems Balanced Scorecard for the market context.
What is the Veeva Systems Founding Story?
Veeva Systems history starts in 2007, when Peter Gassner founded Veeva Systems Company in Pleasanton, California. The brief history of Veeva Systems Company shows a clear early bet: build cloud tools for life sciences teams that fit regulated workflows, not generic software.
Veeva Systems founded its business on one narrow problem first: pharma sales teams needed CRM built for compliance, data control, and field use. That focus shaped the Veeva Systems company overview from day one and helped define the Veeva Systems timeline. For readers tracking how Veeva Systems Company started, the early years were about precision, not scale theater.
- Founded in 2007 by Peter Gassner
- Started in Pleasanton, California
- Launched Veeva CRM first
- Built for life sciences workflows
The Veeva Systems Company origin story was practical and specialist-led. Early buyers likely saw a focused vendor with strong domain knowledge, which mattered in a market where compliance and implementation discipline shape adoption. That is why the company first looked like a narrow but serious player, not a broad platform bet.
Its name stayed consistent, so there was no public rebrand to blur the story. That steadiness helped the Veeva Systems Company background feel stable from the start, and it also supported later Veeva Systems Company growth history as the business expanded beyond its first CRM product. For context on the market it entered, see Target Market of Veeva Systems.
Veeva Systems SWOT Analysis
- Organized to Save Time on Analysis
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of Veeva Systems?
Veeva Systems Company started as a focused CRM player for life sciences and then grew into a broader regulated software platform. Its Veeva Systems history shows a clear shift from sales tools to mission-critical systems used across clinical, regulatory, medical, safety, and quality work.
Veeva Systems was founded in 2007 by Peter Gassner and Matthew Wallach, and its early years centered on cloud CRM for drug and biotech sales teams. That narrow start gave Veeva Systems Company a clear niche in a market that needed regulated workflows, audit trails, and compliance support.
Veeva Vault expanded the company from commercial software into a platform for content, quality, clinical, regulatory, medical, and safety operations. That move made the Veeva Systems Company business evolution much deeper, because customers could run more core work inside one system and stay longer.
The 2013 New York Stock Exchange listing under ticker VEEV gave the Veeva Systems Company IPO history more visibility with institutions and raised the brand profile fast. Over time, the customer base widened across global life sciences, and by fiscal 2025 revenue reached $2.75 billion, showing how the subscription model scaled.
The 2019 Crossix deal added healthcare data and analytics strength, especially for marketing and audience insight. More recently, the shift to Vault CRM has reduced dependence on Salesforce and pushed the Veeva Systems Company timeline toward more control over its own platform roadmap, a key point in the Marketing Strategy of Veeva Systems.
Veeva Systems Ansoff Matrix
- Structured to Support Better Decisions
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
What are the key Milestones in Veeva Systems history?
Veeva Systems Company built its reputation by solving hard regulated-workflow problems in life sciences. In the Veeva Systems history, the shift from CRM to Vault, the 2013 IPO, and long retention at large drugmakers shaped the brief history of Veeva Systems Company into a story of steady growth, low drama, and deep trust.
| Year | Milestone | Impact |
|---|---|---|
| 2007 | Veeva Systems founded by Peter Gassner after leaving sales software roles at other firms. | Started the Veeva Systems Company origin story in cloud software for life sciences. |
| 2013 | Veeva Systems Company IPO history began with its public listing on the NYSE. | Added public-market credibility and wider investor visibility. |
| 2012 | Vault launched as a cloud content and quality platform for regulated work. | Expanded the Veeva Systems company overview beyond CRM. |
| 2024 | Veeva announced plans to make Vault CRM the core commercial platform. | Marked a major shift in Veeva Systems Company business evolution. |
| 2025 | FY2025 revenue reached $2.75 billion, showing continued scale. | Backed the Veeva Systems Company growth history with hard numbers. |
Veeva Systems Company innovations focused on cloud tools built for compliance, traceability, and speed in drug development and sales. That focus helped the Veeva Systems Company milestones stand out because the software had to work inside strict rules, not around them.
Vault turned document, quality, and regulatory work into one cloud platform. That move widened the Veeva Systems Company market expansion beyond CRM.
The original CRM product fit a niche with strict compliance needs. It helped build sticky customer accounts and strong renewal rates.
Early cloud delivery lowered IT friction for pharma teams. That made adoption easier across global accounts.
New modules across clinical, quality, and commercial use cases broadened the platform. This helped lift Veeva Systems Company growth history over time.
Shared life sciences data structures improved consistency across teams. It also made the software harder to replace.
The move toward Vault CRM shows a deeper platform strategy. Read more in the Growth Strategy of Veeva Systems.
Veeva Systems Company challenges have been strategic rather than scandal driven. The main test has been whether it can keep growing outside CRM while serving customers that expect near zero disruption.
Vault CRM adds migration risk because large pharma teams move slowly and demand stability. The shift also raises the bar on execution, integration, and support across the Veeva Systems timeline.
Moving customers to Vault CRM can take time. If upgrades slip, trust can weaken.
Big pharma expects deep support and uptime. That raises costs and execution pressure.
Growing beyond CRM is hard in regulated software. Each new module must fit strict workflows.
Large pharma accounts matter most. That creates pricing and retention pressure.
Shifting core products can confuse buyers. Clear messaging and timing matter.
Veeva Systems stock history reflects strong trust but also high expectations. Investors watch execution closely.
Veeva Systems Balanced Scorecard
- Clean, Modern, and Easy to Present
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What is the Timeline of Key Events for Veeva Systems?
Veeva Systems Company history shows a clear pattern: focus on life sciences, build for regulated work, and keep customers in the center. From 2007 founding to the Vault platform, IPO, and newer CRM shifts, the Veeva Systems timeline explains why the brand still reads as specialized and trusted.
| Year | Key Event |
|---|---|
| 2007 | Veeva Systems was founded in Pleasanton, California, and began building cloud software for life sciences. |
| 2013 | Veeva Systems completed its IPO, marking the move from startup niche to public market growth story. |
| 2019 | Veeva Systems acquired Crossix, adding data and analytics capabilities to its life sciences platform. |
| 2025 | FY2025 revenue reached about 2.75 billion dollars, reinforcing the company's subscription-led model and scale in regulated software. |
The Veeva Systems Company origin story is narrow by design. It started with one hard job: software for life sciences that could handle compliance, process control, and customer data.
Veeva Systems history shows trust was earned through steady delivery, not hype. That matters in a sector where workflow failures can delay trials, launches, or regulatory steps.
The Veeva Systems Company business evolution now centers on modernizing core CRM while keeping regulated workflows stable. If execution stays clean, the platform can deepen its moat in life sciences.
The Veeva Systems Company growth history supports a durable brand because the customer base depends on reliability. For a deeper look at its values and positioning, see Mission, Vision & Core Values of Veeva Systems.
Veeva Systems VRIO Analysis
- Designed for Fast Business Analysis
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What is Customer Demographics and Target Market of Veeva Systems Company?
- What is Sales and Marketing Strategy of Veeva Systems Company?
- What is Growth Strategy and Future Prospects of Veeva Systems Company?
- How Does Veeva Systems Company Work?
- Who Owns Veeva Systems Company?
- What is Competitive Landscape of Veeva Systems Company?
- What are Mission Vision & Core Values of Veeva Systems Company?
Frequently Asked Questions
Veeva Systems was founded in 2007 and entered the market with Veeva CRM. That early focus on life sciences software helped it build credibility fast, especially in a regulated industry where implementation quality matters. By 2013, the company was public, and by FY2024 revenue was about $2.36 billion.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.